Oral GLP-1 pills are set to transform treatment of obesity and weight management
It is recommended to do a patch test first
While genetic predispositions do not predict exact medication response, they can support a more nuanced conversation between you and your provider about dose titration, expected timelines, and whether combination therapy aligns with your metabolic phenotype
Barrel size affects the listed capacity and marking range
In the STEP trials, semaglutide was administered as part of a comprehensive lifestyle intervention that included a reduced-calorie diet (approximately 500 kcal/day deficit based on baseline energy requirements) and a minimum of 150 min of physical activity per week [38,39,40,41,42,43,44,45,46, 78, 97]
You may be a good candidate for GLP-1 treatment if you: Have been diagnosed with type 2 diabetes Have obesity, or a body mass index (BMI) of 30 or higher Have overweight (a BMI of 25 to 29.9) plus at least one weight-related condition, such as heart disease or type 2 diabetes Ultimately, the decision to start treatment for weight loss is up to you and your healthcare provider